A genetics diagnostics company
offering genetics testing to
a global clinical community


Blueprint Genetics provides comprehensive genetics testing for all medical specialties. Blueprints innovative technologies in human rare diseases enable improved tests with higher quality, lower cost and faster lead time. We offer full transparency to our technology, quality and performance, and analytic validations of our technologies.

Our expert team of geneticists and clinicians together with our AI powered CLINT technology provide top quality clinical interpretation and reports, changing the standards of molecular diagnostics. We are accredited by ISO 15189 and CAP (#9257331), and certified by CLIA (#99D2092375).

Inventure joined Blueprint Genetics in 2014.


In treatment of inherited cardiovascular conditions, #genetictesting can serve as a risk assessment tool, clarify inheritance patterns & reveal further family testing needs. Stop by our booth at #SEC19 to hear what we have done to maximize the diagnostic yield for your patients.

#Genetictesting can contribute the diagnosis & treatment of inherited cardiovascular conditions. Look for a test that uses the latest technology, has high-quality interpretation and is clear about the findings, but also about possible limitations. Visit us at #SEC19 to hear more.

Good morning Barcelona! The Blueprint team is attending #SEC19, Congress of Cardiovascular Diseases in Spain. Stop by our booth to meet geneticist Rocio Sanchéz and sales director @daniela_albero to discuss advances in #genetictesting and #cardiology. #GeneticKnowledge